Drug intelligence / Profile preview

trifosadenin

Development stage
Unknown
Lead developer
Laboratoire X.O.
Modality
Small Molecules
Administration
Oral
01

Overview

Atépadène is an oral muscle relaxant containing triphosadenine disodium trihydrate (adenosine triphosphate disodium trihydrate) as its active ingredient. It is indicated as an adjunctive treatment for back pain (dorsalgia) in adults and adolescents over 15 years of age. Adenosine triphosphate (ATP) is a naturally occurring nucleotide that serves as the primary energy currency of cells and plays a critical role in muscle metabolism. By binding to myosin, ATP facilitates muscle relaxation by dissociating actin-myosin cross-bridges, thereby relieving muscle tension and spasm. Atépadène was originally developed by Mayoly Spindler and is currently marketed by Laboratoire X.O (LXO Group).

Brand names
AtepadeneAtépadène
Other names
ATPadenosine triphosphateadenosine triphosphate disodiumadenosine triphosphate disodium saltadenosine triphosphate disodium trihydratedisodium adenosine triphosphatedisodium adenosine triphosphate trihydratetrifosadenintriphosadeninetriphosadenine disodiumtriphosadenine disodium salttriphosadenine disodium trihydratetriphosadéninetriphosadénine disodiquetriphosadénine disodique trihydrate

Beyond the preview

Go deeper on trifosadenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trifosadenin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call